Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

23Andme Holding Co. (NQ: ME )

0.9777 -0.0423 (-4.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,147,899
Open 1.030
Bid (Size) 0.9800 (13)
Ask (Size) 1.000 (7)
Prev. Close 1.020
Today's Range 0.9617 - 1.040
52wk Range 0.9601 - 3.500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
23andMe Announces Poster Presentations on 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2023 Annual Meeting
23andMe to present data on efficacy and safety and dose selection for the ongoing 23ME-00610 Phase 1/2a clinical trial in patients with advanced solid malignancies 
From 23andMe, Inc.
Via GlobeNewswire
23andMe and Sickle Cell 101 Collaborate to Expand Sickle Cell Awareness Program
From 23andMe, Inc.
Via GlobeNewswire

Performance

YTD
-53.44%
-53.44%
1 Month
-11.12%
-11.12%
3 Month
-42.15%
-42.15%
6 Month
-56.74%
-56.74%
1 Year
-65.81%
-65.81%

More News

Read More
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
23andMe Holding's Return On Capital Employed Overview
Via Benzinga
Recap: 23andMe Holding Q4 Earnings
Via Benzinga
23andMe Holding's Earnings Outlook
Via Benzinga
Top 5 Health Care Stocks That May Explode In Q3
Via Benzinga
Why Olin Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Dell Technologies Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
23andMe Granted New FDA Clearance to Report Additional BRCA Variants
From 23andMe, Inc.
Via GlobeNewswire
Better AI Biotech Stock: Recursion Pharmaceuticals vs. 23andMe
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why 23andMe Holding Stock Plummeted by 13% Today
Via The Motley Fool
23andMe Reports FY2024 First Quarter Financial Results
From 23andMe, Inc.
Via GlobeNewswire
23andMe to Report FY2024 First Quarter Financial Results
From 23andMe, Inc.
Via GlobeNewswire
23andMe Releases New FDA-Cleared Genetic Report on Simvastatin, a Commonly Prescribed Statin
From 23andMe, Inc.
Via GlobeNewswire
23andMe Releases New Report Revealing Genetic Likelihood of Experiencing Panic Attacks
From 23andMe, Inc.
Via GlobeNewswire
3 Gene Testing Stocks to Buy Before They Take Off
Via InvestorPlace
23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results
From 23andMe, Inc.
Via GlobeNewswire
Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics
Via The Motley Fool
3 Key Biotech Trends for 2023 And Beyond
Via The Motley Fool
Hero or Zero? 3 High-Risk Penny Stocks to Make You Rich … or Broke.
Via InvestorPlace
New 23andMe survey reveals nine out of ten physicians in the U.S. believe genetics play an important part of a patient’s complete health picture
From 23andMe, Inc.
Via GlobeNewswire
3 Personalized Medicine Stocks to Buy for Long-Time Returns
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.